Literature DB >> 21816834

Occlusive thrombi arise in mammals but not birds in response to arterial injury: evolutionary insight into human cardiovascular disease.

Alec A Schmaier1, Timothy J Stalker, Jeffrey J Runge, Dooyoung Lee, Chandrasekaran Nagaswami, Patricia Mericko, Mei Chen, Simon Cliché, Claude Gariépy, Lawrence F Brass, Daniel A Hammer, John W Weisel, Karen Rosenthal, Mark L Kahn.   

Abstract

Mammalian platelets are small, anuclear circulating cells that form tightly adherent, shear-resistant thrombi to prevent blood loss after vessel injury. Platelet thrombi that form in coronary and carotid arteries also underlie common vascular diseases such as myocardial infarction and stroke and are the target of drugs used to treat these diseases. Birds have high-pressure cardiovascular systems like mammals but generate nucleated thrombocytes rather than platelets. Here, we show that avian thrombocytes respond to many of the same activating stimuli as mammalian platelets but are unable to form shear-resistant aggregates ex vivo. Avian thrombocytes are larger than mammalian platelets, spread less efficiently on collagen, and express much lower levels of the α(₂b)β₃ integrin required for aggregate formation, features predicted to make thrombocyte aggregates less resistant than platelets are to the high fluid shear forces of the arterial vasculature. In vivo carotid vessel injury stimulates the formation of occlusive platelet thrombi in mice but not in the size- and flow-matched carotid artery of the Australian budgerigar. These studies indicate that unique physical and molecular features of mammalian platelets enable them to form shear-resistant arterial thrombi, an essential element in the pathogenesis of human cardiovascular diseases.

Entities:  

Mesh:

Year:  2011        PMID: 21816834      PMCID: PMC3186337          DOI: 10.1182/blood-2011-02-338244

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  The evolution of maximum body size of terrestrial mammals.

Authors:  Felisa A Smith; Alison G Boyer; James H Brown; Daniel P Costa; Tamar Dayan; S K Morgan Ernest; Alistair R Evans; Mikael Fortelius; John L Gittleman; Marcus J Hamilton; Larisa E Harding; Kari Lintulaakso; S Kathleen Lyons; Christy McCain; Jordan G Okie; Juha J Saarinen; Richard M Sibly; Patrick R Stephens; Jessica Theodor; Mark D Uhen
Journal:  Science       Date:  2010-11-26       Impact factor: 47.728

2.  In vitro studies of aggregation of non-mammalian thrombocytes.

Authors:  F A Belamarich; M H Fusari; D Shepro; M Kien
Journal:  Nature       Date:  1966-12-31       Impact factor: 49.962

3.  Flow cytometric analysis of the platelet surface area and surface density of glycoprotein IIb-IIIa of unactivated human platelets of various sizes.

Authors:  V Leytin; H Shapiro; I Novikov; J Radnay
Journal:  Biochem Biophys Res Commun       Date:  1996-09-04       Impact factor: 3.575

4.  Punctuated equilibrium in evolution and the platelet.

Authors:  J F Martin
Journal:  Eur J Clin Invest       Date:  1994-04       Impact factor: 4.686

5.  GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow.

Authors:  Kendra L Sarratt; Hong Chen; Mary M Zutter; Samuel A Santoro; Daniel A Hammer; Mark L Kahn
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

6.  Critical role of ADP interaction with P2Y12 receptor in the maintenance of alpha(IIb)beta3 activation: association with Rap1B activation.

Authors:  T Kamae; M Shiraga; H Kashiwagi; H Kato; S Tadokoro; Y Kurata; Y Tomiyama; Y Kanakura
Journal:  J Thromb Haemost       Date:  2006-06       Impact factor: 5.824

7.  Origin and evolution of the Ig-like domains present in mammalian leukocyte receptors: insights from chicken, frog, and fish homologues.

Authors:  Nikolas Nikolaidis; Jan Klein; Masatoshi Nei
Journal:  Immunogenetics       Date:  2005-02-09       Impact factor: 2.846

Review 8.  Platelets in atherothrombosis: lessons from mouse models.

Authors:  B Nieswandt; B Aktas; A Moers; U J H Sachs
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

9.  Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators.

Authors:  J E Tcheng; R A Harrington; K Kottke-Marchant; N S Kleiman; S G Ellis; D J Kereiakes; M J Mick; F I Navetta; J E Smith; S J Worley
Journal:  Circulation       Date:  1995-04-15       Impact factor: 29.690

10.  Localization of fibrinogen during aggregation of avian thrombocytes.

Authors:  E T O'Toole; R R Hantgan; J C Lewis
Journal:  Exp Mol Pathol       Date:  1994-12       Impact factor: 3.362

View more
  16 in total

1.  Hemostasis stimulates lymphangiogenesis through release and activation of VEGFC.

Authors:  Lillian Lim; Hung Bui; Olivia Farrelly; Jisheng Yang; Li Li; David Enis; Wanshu Ma; Mei Chen; Guillermo Oliver; John D Welsh; Mark L Kahn
Journal:  Blood       Date:  2019-11-14       Impact factor: 22.113

2.  The origin of platelets enabled the evolution of eutherian placentation.

Authors:  John F Martin; Günter P Wagner
Journal:  Biol Lett       Date:  2019-07-10       Impact factor: 3.703

3.  To deform or not to deform: the evolutionary basis of mammalian red blood cell deformability.

Authors:  Valerie Tutwiler
Journal:  Biophys J       Date:  2021-08-03       Impact factor: 3.699

4.  αIIbβ3 variants defined by next-generation sequencing: predicting variants likely to cause Glanzmann thrombasthenia.

Authors:  Lorena Buitrago; Augusto Rendon; Yupu Liang; Ilenia Simeoni; Ana Negri; Marta Filizola; Willem H Ouwehand; Barry S Coller
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-31       Impact factor: 11.205

5.  Platelets in pulmonary vascular physiology and pathology.

Authors:  Michael H Kroll; Vahid Afshar-Kharghan
Journal:  Pulm Circ       Date:  2012-07       Impact factor: 3.017

6.  A refined model of the genomic basis for phenotypic variation in vertebrate hemostasis.

Authors:  Ângela M Ribeiro; M Lisandra Zepeda-Mendoza; Mads F Bertelsen; Annemarie T Kristensen; Erich D Jarvis; M Thomas P Gilbert; Rute R da Fonseca
Journal:  BMC Evol Biol       Date:  2015-06-30       Impact factor: 3.260

Review 7.  Origins of the Vertebrate Erythro/Megakaryocytic System.

Authors:  Ondrej Svoboda; Petr Bartunek
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

8.  Characterization of zebrafish von Willebrand factor reveals conservation of domain structure, multimerization, and intracellular storage.

Authors:  Arunima Ghosh; Andy Vo; Beverly K Twiss; Colin A Kretz; Mary A Jozwiak; Robert R Montgomery; Jordan A Shavit
Journal:  Adv Hematol       Date:  2012-09-24

9.  Heightened activation of embryonic megakaryocytes causes aneurysms in the developing brain of mice lacking podoplanin.

Authors:  Christopher Hoover; Yuji Kondo; Bojing Shao; Michael J McDaniel; Robert Lee; Samuel McGee; Sidney Whiteheart; Wolfgang Bergmeier; Rodger P McEver; Lijun Xia
Journal:  Blood       Date:  2021-05-20       Impact factor: 25.476

10.  Platelets in hemostasis and thrombosis: Novel mechanisms of fibrinogen-independent platelet aggregation and fibronectin-mediated protein wave of hemostasis.

Authors:  Yan Hou; Naadiya Carrim; Yiming Wang; Reid C Gallant; Alexandra Marshall; Heyu Ni
Journal:  J Biomed Res       Date:  2015-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.